Navigation Links
Two Biotech Companies Join Science Center’s Port Community
Date:12/12/2013

Philadelphia, PA (PRWEB) December 12, 2013

Two new biotechnology companies, Targeted Therapeutic Solutions, LLC and Innolign Biomedical, LLC have begun operations at the University City Science Center’s Port business incubator at 3711 Market Street, in Philadelphia.

Both startups launched as part of the University of Pennsylvania’s UPstart Program. They will utilize laboratory and office space at the Science Center to pursue product research and development programs. They have each received Phase 1 Small Business Innovation Research (SBIR) funding from the National Institutes of Health.

Targeted Therapeutic Solutions LLC (TTS), is currently developing one of their lead technologies, a unique agent that can potentially reduce the incidence of stroke and its associated maladies. This therapeutic approach has the potential for reducing bleeding risk than existing clinical agents, making this technology useful for patients with or at risk for pulmonary embolism, deep vein thrombosis and certain types of heart attacks.

Innolign Biomedical is a biotechnology company utilizing its novel microfabrication technologies and expertise in tissue engineering to develop high throughput organ-on-chip assessment platforms for the pharmaceutical industry and to design novel biomaterials as products for promoting therapeutic tissue regeneration.

“These two new companies complement the diverse composition of the Science Center’s Port incubator,” Science Center Vice President Science & Technology Christopher J. Laing, MRCVS, Ph.D., said. “The University of Pennsylvania’s UPstart Program is creating an exciting pipeline of startups in biotech and emerging technologies. We are delighted to provide an ecosystem that will allow these companies to continue to grow.”

As of Dec. 1, the 45 current residents of the Port include startups in life sciences, healthcare, IT, emerging technologies and support organizations. Combined, they deploy more than $27 million in risk capital, and employ 92 people.

About the Science Center
The University City Science Center is a dynamic hub for innovation, entrepreneurship and technology development in the Greater Philadelphia region. Its Port facility provides business incubation, programming, lab and office facilities and support services for entrepreneurs, startups, growing and established companies. The Science Center was the first, and remains the largest, urban research park in the United States. Since it was founded in 1963, graduate organizations and current residents of the Port business incubator have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually. The Science Center is celebrating its 50th anniversary in 2013. For more information, visit sciencecenter.org.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11415515.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
2. Puma Biotechnology Announces Completion of Private Placement
3. Animal Biotechnology - Technologies, Markets and Companies
4. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
5. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
6. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
7. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
8. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
9. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
10. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
11. Selexis SA to Present at Biotech Showcase 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 23, 2017 , ... ... relocatable and permanent modular buildings, announced the launch of the Mobile Big ... design characteristics to help support on-site teamwork and collaboration. , The Mobile ...
(Date:5/23/2017)... ... May 23, 2017 , ... A recent survey conducted by the Weed ... to control weed in 12 categories of broadleaf crops, fruits and vegetables, while common ... the U.S. and Canada participated in the 2016 survey, the second conducted by WSSA. ...
(Date:5/23/2017)... ... May 23, 2017 , ... Vortex Biosciences , ... “Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology ” in Nature ... a collaboration with Dr. Dino Di Carlo and Dr. Matthew Rettig at the University ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... re-engineer their control technology again and again. METTLER TOLEDO has released two new ... The videos illustrate how integration of the ACT350 into Siemens and Allen Bradley ...
Breaking Biology Technology:
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
Breaking Biology News(10 mins):